Study Finds Avandia Does Not Lead to Heart Attacks
July 14, 2010
A study released at the American Diabetes Association Annual meeting finds the diabetes drug Avandia does not increase the risk for heart attack, contradicting recent reports.
Topics:
Health Medical Pharma, Diabetes, Health, Medicine, Myocardial infarction, American Diabetes Association, diabetes mellitus, Aging-associated diseases, Thiazolidinediones, Rosiglitazone, Pyridines, GlaxoSmithKline, Avandia, heart attack, the American Diabetes Association annual, Finds Avandia Does Not Lead to Heart Attacks A, Politics